Abstract
Malignant hemopathies are a group of diseases related to hematopoiesis disorders with malignant behavior and evolution. Ocular involvement is rare and polymorphous. It may be due to direct infiltration of the eye by neoplastic cells or secondary to hematologic abnormalities. The correlation between hematologic abnormalities and ophthalmological manifestations has been well demonstrated. Ophthalmological symptoms may reveal the disease or indicate a relapse. It is an independent prognostic indicator. The aim of this study was to highlight the characteristics of ocular disorders during malignant hemopathies
Reference30 articles.
1. [1] Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83‐87.
2. [2]Jarrett WF, Mackey LJ. Neoplastic diseases of the haematopoietic and lymphoid tissues. Bull World Health Organ. 1974; 50:21‐34.
3. [3] Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Michelle M Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 ;127 :2391‐2405.
4. [4]Silva JR Jr, Hayashi D, Yonenaga T, Fukuda K, Genant HK, Lin C, et al. MRI of bone marrow abnormalities in hematological malignancies. Diagn Interv Radiol. 2013;19:393‐99.
5. [5]Orhan B, Malbora B, Akça Bayar S, Avcı Z, Alioğlu B, Özbek N. Ophthalmologic Findings in Children with Leukemia: A Single-Center Study. Turk J Ophthalmol. 2016;46:62‐7.